Guangzhou Regenerative Medicine and Health Guangdong Laboratory (Bioisland Laboratory) was founded on 22nd December 2017, it is operated as a public research institution as one of the first provincial laboratories to develop as the reserves of national laboratories in Guangdong Province. Bioisland Laboratory aims at addressing major strategic needs of Guangdong Province and the whole country through 5 research areas and is committed to become a pioneer of international scientific research in stem cell and regenerative medicine, which covers from fundamental science to translational and clinical research.
The AI drug design group in Bioisland Laboratory aims to develop novel AI algorithms to facilitate drug discovery and provide computational chemistry support for both in-house and collaborative drug discovery projects with external partners. It has the state-of-the-art computational tools and high performance computing hardware.